Texas vs California Cannabis Laws

Texas has one of the most restrictive medical cannabis programs in the country. The Texas Compassionate Use Act, signed in 2015, created the Compassionate Use Program (CUP), initially limited to patients with intractable epilepsy and restricted to low-THC cannabis products. HB 1535, passed in 2021, expanded the program to include additional qualifying conditions such as cancer, PTSD, and certain neurodegenerative diseases, and raised the THC cap from 0.5% to 1%. Despite these expansions, the program remains far more limited than standard medical cannabis programs in other states.

The Texas market structure is extraordinarily restrictive. Only 3 vertically integrated dispensing organizations are licensed to operate statewide, serving a population of approximately 30 million people. This creates significant access challenges for patients, as the limited number of dispensary locations cannot adequately serve the state's vast geography. Products are limited to low-THC cannabis preparations, and the 1% THC cap means patients cannot access the full-potency products available in most medical states.

Despite being the second most populous state, Texas generates modest cannabis revenue estimated at roughly $50 million annually from its CUP program. The extremely limited license structure, low THC cap, and restricted qualifying conditions severely constrain the market. No major MSOs currently operate in Texas, as the 3 existing licenses are held by local operators. If Texas were to significantly expand its medical program or legalize recreational cannabis, it would instantly become one of the largest cannabis markets in the world. Market analysts estimate a fully legalized Texas market could generate $3-5 billion in annual sales, making it a closely watched state for potential reform.

California is the largest legal cannabis market in the world, generating over $5 billion in annual licensed sales. The state has a storied history with cannabis, becoming the first in the nation to legalize medical use through Proposition 215 (the Compassionate Use Act) in 1996. Recreational legalization followed with Proposition 64 in 2016, and adult-use sales began on January 1, 2018.

Despite its enormous size, California's cannabis market faces significant challenges. A massive illicit market — estimated at two to three times the size of the legal market — continues to undercut licensed operators. The state's regulatory framework is complex, with the Department of Cannabis Control overseeing state licenses while individual cities and counties retain the authority to permit or ban cannabis businesses. As of 2025, the majority of California's 482 cities still do not allow retail cannabis sales, limiting legal access.

The state eliminated its cultivation tax in 2023 to ease the burden on growers, but the 15% excise tax on retail sales remains, along with local taxes that can push the combined effective tax rate above 30% in some jurisdictions. Major MSOs including Curaleaf, Trulieve, Cresco Labs, and TerrAscend maintain California operations, though the market is also home to hundreds of independent operators. The sheer scale and brand-building potential of California make it a strategic priority despite its competitive difficulties.